The YKL-40 protein is a potential biomarker for COPD: A meta-analysis and systematic review
International Journal of COPD | Feb 08, 2018
Tong X, et al. - The role of YKL-40 in COPD was investigated via a systematic review and meta-analysis. The analyzed evidence suggested possible implication of YKL-40 in bronchial inflammation and remodeling in COPD. Also, YKL-40 may be considered as a useful biomarker for COPD diagnosis and monitoring.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
